Prognosis of pulmonary arterial hypertension patients with pericardial effusion before and after initiation of parenteral prostacyclin therapy

Few studies have evaluated the effects of pulmonary arterial hypertension therapies on pericardial effusion. We evaluated hemodynamics, echocardiograms, and outcomes for 119 parenteral prostanoid‐treated patients. We discovered an increased frequency of pericardial effusions posttreatment, and that...

Full description

Saved in:
Bibliographic Details
Published inPulmonary circulation Vol. 13; no. 2; pp. e12226 - n/a
Main Authors Abu‐Rmaileh, Muhammad, Mirza, Omer, Patel, Chandni, Shah, Trushil, Hardin, Elizabeth A., Bartolome, Sonja D., Chin, Kelly M.
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.04.2023
John Wiley and Sons Inc
Wiley
Subjects
Echocardiogram
Hemodynamics
Intubation
Medical prognosis
Missing data
Mortality
Pericardial Effusion
Prostacylcline Therapy
Pulmonary Arterial Hypertension
Pulmonary hypertension
Research Letter
Ultrasonic imaging
Variance analysis
Pericardial Effusion
Echocardiogram
Pulmonary Arterial Hypertension
Prostacylcline Therapy
Online AccessGet full text

Cover

More Information
Summary:Few studies have evaluated the effects of pulmonary arterial hypertension therapies on pericardial effusion. We evaluated hemodynamics, echocardiograms, and outcomes for 119 parenteral prostanoid‐treated patients. We discovered an increased frequency of pericardial effusions posttreatment, and that a moderate‐large pericardial effusion at initiation, but not at 1st follow‐up, was significantly associated with mortality.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2045-8940
2045-8932
2045-8940
DOI:10.1002/pul2.12226